The recent uptick and rise in popularity of GLP-1 drugs for addressing ... potential generic competitors starting in 2017. FDA approved the first generic drug containing liraglutide in December ...

In the past 20 years, the average rate of obesity among adults in the United States has risen by approximately 30 percent, but the rate of those with the most severe forms of obesity, or those with a ...

Chris Garten, R-Charlestown—met briefly to formally launch the process of finalizing a bill. They’re starting with the Senate passed version of the bill—approved 29-19—which threatens to ...

In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S.

Biotech executives and venture capital investors are banding together to press Congress to act on FDA layoffs they say are already impacting drug development. In a letter to Bill Cassidy, R-La ...

Some telehealth companies that offered compounded GLP-1s have disappeared altogether. Others are pursuing strategies that ...

Spending on Ozempic, Wegovy and other similar prescriptions soared 500 percent in five years, according to a research letter.

Let's look at why this news could be a game-changer for Eli Lilly and its stock.